Novel prognostic tools that identify high-risk follicular lymphoma

被引:1
|
作者
Luminari, Stefano [1 ,2 ]
机构
[1] Azienda Unita Sanit Locale IRCCS, Hematol Unit, Reggio Emilia, Italy
[2] Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Related Transpla, Reggio Emilia, Italy
来源
HEMASPHERE | 2019年 / 3卷
关键词
PROGRESSION-FREE SURVIVAL; MINIMAL RESIDUAL DISEASE; METABOLIC TUMOR VOLUME; POOLED ANALYSIS; VALIDATION; TRIAL;
D O I
10.1097/HS9.0000000000000214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Take home messages In 20% to 30% of patients with follicular lymphoma (FL), the disease shows an aggressive behavior. Novel biomarkers are available in FL each with a different ability to identify high-risk patients. Further improvement in the management of FL will likely be achieved by means of risk adapted therapies.
引用
收藏
页码:82 / 84
页数:3
相关论文
共 50 条
  • [1] Is the follicular lymphoma international prognostic index better than the international prognostic index to identify high-risk follicular lymphoma patients?
    Etto, Leina Yukari
    Silva, Vanderleia Costa
    Inaoka, Riguel Jun
    Costa, Roberta Pasianotto
    Alves, Antonio Correa
    Colleoni, Gisele W. B.
    LEUKEMIA & LYMPHOMA, 2007, 48 (03) : 526 - 530
  • [2] PROGNOSTIC FACTORS IN FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA: HOW TO IDENTIFY A HIGH-RISK PATIENT?
    Prochazka, Vit
    Papajik, Tomas
    Jarosova, Marie
    Indrak, Karel
    BIOMEDICAL PAPERS-OLOMOUC, 2011, 155 (02): : 99 - 108
  • [3] Treatment of high-risk follicular lymphoma
    Jurczak, Wojciech
    HEMASPHERE, 2019, 3 : 85 - 87
  • [5] High-risk follicular lymphoma: Treatment options
    Kahl, Brad
    HEMATOLOGICAL ONCOLOGY, 2021, 39 : 94 - 99
  • [6] Upfront identification of high-risk follicular lymphoma
    Casulo, Carla
    HEMATOLOGICAL ONCOLOGY, 2021, 39 : 88 - 93
  • [7] Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome
    Muntanola, Ana
    Mozas, Pablo
    Mercadal, Santiago
    Huguet, Maria
    Bobillo, Sabela
    Bastos-Oreiro, Mariana
    Jimenez-Ubieto, Ana
    Rovira, Jordina
    Rivero, Andrea
    Tolosa, Carles
    Luizaga, Luis
    Gonzalez de Villambrosia, Sonia
    Novelli, Silvana
    Caballero, Dolores
    Salar, Antonio
    Alonso-Alvarez, Sara
    Magnano, Laura
    Gutierrez, Norma C.
    Sancho, Juan-Manuel
    Lopez-Guillermo, Armando
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (03) : 306 - 314
  • [8] Follicular lymphoma with marginal zone differentiation: cytogenetic findings in support of a high-risk variant of follicular lymphoma
    Goodlad, JR
    Batstone, PJ
    Hamilton, D
    Hollowood, K
    HISTOPATHOLOGY, 2003, 42 (03) : 292 - 298
  • [9] PET Evaluation Before Autografting Has a Strong Prognostic Impact in High-Risk, Relapsed Follicular Lymphoma Patients
    Ysebaert, Loic
    Dupuis, Jehan
    Meignan, Michel
    Julian, Anne
    Recher, Christian
    Roussel, Murielle
    Oberic, Lucie
    Belhadj, Karim
    Rigal-Huguet, Francoise
    Huynh, Anne
    Laurent, Camille
    Gaulard, Philippe
    Attal, Michel
    Haioun, Corinne
    Laurent, Guy
    BLOOD, 2011, 118 (21) : 701 - 701
  • [10] R-FND Followed by Radioimmunotherapy for High-Risk Follicular Lymphoma
    McLaughlin, Peter
    Neelapu, Sattva
    Fanale, Michelle
    Rodriguez, Maria
    Ayala, Ana
    Pro, Barbara
    Hagemeister, F. B.
    Younes, Anas
    Neel, Susan
    Fowler, Nathan
    Hess, Mark
    Kwak, Larry W.
    BLOOD, 2008, 112 (11) : 1050 - 1051